36 filings
8-K
RLAY
Relay Therapeutics Inc
22 Feb 24
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
RLAY
Relay Therapeutics Inc
2 Nov 23
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
8-K
RLAY
Relay Therapeutics Inc
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
8-K
7bukzh90fmtwk 22tno
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
zs1hlsbo9nd
25 May 23
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
5:05pm
8-K
e86k a7gfxn1i2z0d0l
4 May 23
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
n0mi ebpygunx8j
18 Apr 23
Regulation FD Disclosure
10:42am
8-K
2srujm9
23 Feb 23
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:11pm
8-K
hy3a77bzg 2q1z6b
9 Jan 23
JPM Presentation January 2023
7:01am
8-K
ott840gq0qqmb6rci4
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
8-K
kn8a7raw 72mpble8
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
8-K
bx7532 qtemidjrtuh
12 Sep 22
Enrollment for the pivotal cohort anticipated to be completed in the second half of 2023
6:05am
8-K
su3 tm6602d
8 Sep 22
Regulation FD Disclosure
6:31am
8-K
cogx nlog7swe35
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
lh9 a7qp0tk9vw
27 Jul 22
Departure of Directors or Certain Officers
8:01am
8-K
r4rqmrmpervc0
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
vb55 mhy8fq7
27 May 22
Amendments to Articles of Incorporation or Bylaws
4:37pm
8-K
j6l6uk 5q4lc
5 May 22
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
12:00am